Objective: Both chronic hepatitis B (CHB) and hepatosteatosis may lead to necroinflammation in liver. Therefore, the presence of hepatosteatosis might negatively affect the efficacy of antiviral therapy. We aimed to determine the effect of hepatosteatosis on virological response in patients with CHB receiving entecavir (ETV) and tenofovir (TDF) treatment. Methods: The study was designed retrospectively. All patients receiving antiviral therapy due to CHB in the departments of Infectious Diseases and Clinical Microbiology of 29 different hospitals between January 2012 and June 2017 were searched by examining medical records. Results: A total of 1069 patients were included. Six hundred and fifty of the patients had been receiving TDF and 419 ...
ObjectiveTo investigate the antiviral effect of tenofovir disoproxil fumarate (TDF) versus entecavir...
Objective: To compare responses to tenofovir (TDF) and entecavir (ETV) therapy. Methods: This was a ...
Background and Objectives: Chronic viral hepatitis B is a global health problem, which, if not treat...
Objective: Both chronic hepatitis B (CHB) and hepatosteatosis may lead to necroinflammation in liver...
Background/Aim: Hepatic steatosis may influence the response to antivirals in chronic hepatitis B pa...
Background. This study is to systematically analyze the effects of hepatosteatosis on the response t...
Background/Aims: We aimed to evaluate the impact of non-alcoholic fatty liver disease (NAFLD) on vir...
Background/Aims: This study aimed to evaluate the antiviral response and safety of tenofovir (TDF) v...
Objectives: The aim of this study was to evaluate histopathological improvement and virological, bio...
The coexistence of HBV infection and nonalcoholic fatty liver disease (NAFLD) becomes characteristic...
BACKGROUND/AIMS: The influence of hepatic steatosis (HS) on chronic hepatitis B (CHB) is unclear. We...
Chronicity of hepatitis B (CHB) infection is characterized by a weak immune response to the virus. E...
Objective: The aim of this study to evaluate histopathological improvement and virological, serologi...
Background and aims. CD4+ T cells play an important role in response to hepatitis B virus (HBV) infe...
The coexistence of HBV infection and nonalcoholic fatty liver disease (NAFLD) becomes characteristic...
ObjectiveTo investigate the antiviral effect of tenofovir disoproxil fumarate (TDF) versus entecavir...
Objective: To compare responses to tenofovir (TDF) and entecavir (ETV) therapy. Methods: This was a ...
Background and Objectives: Chronic viral hepatitis B is a global health problem, which, if not treat...
Objective: Both chronic hepatitis B (CHB) and hepatosteatosis may lead to necroinflammation in liver...
Background/Aim: Hepatic steatosis may influence the response to antivirals in chronic hepatitis B pa...
Background. This study is to systematically analyze the effects of hepatosteatosis on the response t...
Background/Aims: We aimed to evaluate the impact of non-alcoholic fatty liver disease (NAFLD) on vir...
Background/Aims: This study aimed to evaluate the antiviral response and safety of tenofovir (TDF) v...
Objectives: The aim of this study was to evaluate histopathological improvement and virological, bio...
The coexistence of HBV infection and nonalcoholic fatty liver disease (NAFLD) becomes characteristic...
BACKGROUND/AIMS: The influence of hepatic steatosis (HS) on chronic hepatitis B (CHB) is unclear. We...
Chronicity of hepatitis B (CHB) infection is characterized by a weak immune response to the virus. E...
Objective: The aim of this study to evaluate histopathological improvement and virological, serologi...
Background and aims. CD4+ T cells play an important role in response to hepatitis B virus (HBV) infe...
The coexistence of HBV infection and nonalcoholic fatty liver disease (NAFLD) becomes characteristic...
ObjectiveTo investigate the antiviral effect of tenofovir disoproxil fumarate (TDF) versus entecavir...
Objective: To compare responses to tenofovir (TDF) and entecavir (ETV) therapy. Methods: This was a ...
Background and Objectives: Chronic viral hepatitis B is a global health problem, which, if not treat...